Inecalcitol, an analog of 1,25D3, displays enhanced antitumor activity through the induction of apoptosis in a squamous cell carcinoma model system

Cell Cycle

Volumn 12, Issue 5, 2013, Pages 743-752

  Ma, Yingyu ^a   Yu, Wei Dong ^a   Hidalgo, Alejandro A ^a   Luo, Wei ^a   Delansorne, Remi ^b   Johnson, Candace S ^a   Trump, Donald L ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b Hybrigenics SA   (France)

Author keywords

Apoptosis; Inecalcitol; SCC; TX522

Indexed keywords

CALCITRIOL; CASPASE 10; CASPASE 3; CASPASE 8; INECALCITOL; MESSENGER RNA; TX 522; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR; X LINKED INHIBITOR OF APOPTOSIS;

ANIMAL CELL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE CHECKPOINT; CELL PROLIFERATION; CONTROLLED STUDY; DRUG HALF LIFE; HYPERCALCEMIA; IC 50; IN VITRO STUDY; IN VIVO CULTURE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH; XENOGRAFT;

EID: 84874642956     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.23846     Document Type: Article

References (29)

1. Deeb KK, Trump DL, Johnson CS. Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer 2007; 7:684-700; PMID:17721433; http://dx.doi.org/10.1038/nrc2196
2. Brown AJ, Dusso A, Slatopolsky E. Vitamin D. Am J Physiol 1999; 277:F157-75; PMID:10444570
3. Verlinden L, Verstuyf A, Quack M, Van Camp M, Van Etten E, De Clercq P, et al. Interaction of two novel 14-epivitamin D3 analogs with vitamin D3 receptorretinoid X receptor heterodimers on vitamin D3 responsive elements. J Bone Miner Res 2001; 16:625-38; PMID:11315990; http://dx.doi.org/10.1359/jbmr. 2001.16.4.625
4. Eelen G, Verlinden L, Rochel N, Claessens F, De Clercq P, Vandewalle M, et al. Superagonistic action of 14-epi-analogs of 1,25-dihydroxyvitamin D explained by vitamin D receptor-coactivator interaction. Mol Pharmacol 2005; 67:1566-73; PMID:15728261; http://dx.doi.org/10.1124/mol.104.008730
5. Verlinden L, Verstuyf A, Van Camp M, Marcelis S, Sabbe K, Zhao XY, et al. Two novel 14-Epi-analogues of 1,25-dihydroxyvitamin D3 inhibit the growth of human breast cancer cells in vitro and in vivo. Cancer Res 2000; 60:2673-9; PMID:10825140
6. Okamoto R, Delansorne R, Wakimoto N, Doan NB, Akagi T, Shen M, et al. Inecalcitol, an analog of 1α,25(OH)(2) D(3), induces growth arrest of androgen-dependent prostate cancer cells. Int J Cancer 2012; 130:2464-73; PMID:21732345; http://dx.doi. org/10.1002/ijc.26279
7. Ma Y, Yu WD, Hershberger PA, Flynn G, Kong RX, Trump DL, et al. 1alpha,25-Dihydroxyvitamin D3 potentiates cisplatin antitumor activity by p73 induction in a squamous cell carcinoma model. Mol Cancer Ther 2008; 7:3047-55; PMID:18790784; http://dx.doi.org/10.1158/1535-7163.MCT-08-0243
8. Hidalgo AA, Deeb KK, Pike JW, Johnson CS, Trump DL. Dexamethasone enhances 1alpha,25-dihydroxyvitamin D3 effects by increasing vitamin D receptor transcription. J Biol Chem 2011; 286:36228-37; PMID:21868377; http://dx.doi.org/10.1074/jbc. M111.244061
9. Hershberger PA, McGuire TF, Yu WD, Zuhowski EG, Schellens JH, Egorin MJ, et al. Cisplatin potentiates 1,25-dihydroxyvitamin D3-induced apoptosis in association with increased mitogen-activated protein kinase kinase kinase 1 (MEKK-1) expression. Mol Cancer Ther 2002; 1:821-9; PMID:12492115
10. Li L, Ittmann MM, Ayala G, Tsai MJ, Amato RJ, Wheeler TM, et al. The emerging role of the PI3-K-Akt pathway in prostate cancer progression. Prostate Cancer Prostatic Dis 2005; 8:108-18; PMID:15724144; http://dx.doi.org/10.1038/ sj.pcan.4500776
11. Song G, Ouyang G, Bao S. The activation of Akt/PKB signaling pathway and cell survival. J Cell Mol Med 2005; 9:59-71; PMID:15784165; http://dx.doi. org/10.1111/j.1582-4934.2005.tb00337.x
12. Garland CF, Garland FC, Gorham ED, Lipkin M, Newmark H, Mohr SB, et al. The role of vitamin D in cancer prevention. Am J Public Health 2006; 96:252-61; PMID:16380576; http://dx.doi.org/10.2105/AJPH.2004.045260
13. Giovannucci E, Liu Y, Rimm EB, Hollis BW, Fuchs CS, Stampfer MJ, et al. Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst 2006; 98:451-9; PMID:16595781; http://dx.doi.org/10.1093/jnci/djj101
14. Hershberger PA, Modzelewski RA, Shurin ZR, Rueger RM, Trump DL, Johnson CS. 1,25-Dihydroxycholecalciferol (1,25-D3) inhibits the growth of squamous cell carcinoma and down-modulates p21(Waf1/Cip1) in vitro and in vivo. Cancer Res 1999; 59:2644-9; PMID:10363987
15. Light BW, Yu WD, McElwain MC, Russell DM, Trump DL, Johnson CS. Potentiation of cisplatin antitumor activity using a vitamin D analogue in a murine squamous cell carcinoma model system. Cancer Res 1997; 57:3759-64; PMID:9288784
16. Ma Y, Yu WD, Kong RX, Trump DL, Johnson CS. Role of nongenomic activation of phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase 1/2 pathways in 1,25D3-mediated apoptosis in squamous cell carcinoma cells. Cancer Res 2006; 66:8131-8; PMID:16912191; http://dx.doi.org/10.1158/0008-5472.CAN-06-1333
17. McGuire TF, Trump DL, Johnson CS. Vitamin D(3)-induced apoptosis of murine squamous cell carcinoma cells. Selective induction of caspase-dependent MEK cleavage and up-regulation of MEKK-1. J Biol Chem 2001; 276:26365-73; PMID:11331275; http://dx.doi. org/10.1074/jbc.M010101200
18. Narvaez CJ, Welsh J. Role of mitochondria and caspases in vitamin D-mediated apoptosis of MCF-7 breast cancer cells. J Biol Chem 2001; 276:9101-7; PMID:11053435; http://dx.doi.org/10.1074/jbc. M006876200
19. Mathiasen IS, Sergeev IN, Bastholm L, Elling F, Norman AW, Jäättelä M. Calcium and calpain as key mediators of apoptosis-like death induced by vitamin D compounds in breast cancer cells. J Biol Chem 2002; 277:30738-45; PMID:12072431; http://dx.doi. org/10.1074/jbc. M201558200
20. Díaz GD, Paraskeva C, Thomas MG, Binderup L, Hague A. Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: possible implications for prevention and therapy. Cancer Res 2000; 60:2304-12; PMID:10786699
21. Guzey M, Kitada S, Reed JC. Apoptosis induction by 1alpha,25- dihydroxyvitamin D3 in prostate cancer. Mol Cancer Ther 2002; 1:667-77; PMID:12479363
22. Jiang F, Bao J, Li P, Nicosia SV, Bai W. Induction of ovarian cancer cell apoptosis by 1,25-dihydroxyvitamin D3 through the down-regulation of telomerase. J Biol Chem 2004; 279:53213-21; PMID:15485861; http://dx.doi.org/10. 1074/jbc.M410395200
23. Pepper C, Thomas A, Hoy T, Milligan D, Bentley P, Fegan C. The vitamin D3 analog EB1089 induces apoptosis via a p53-independent mechanism involving p38 MAP kinase activation and suppression of ERK activity in B-cell chronic lymphocytic leukemia cells in vitro. Blood 2003; 101:2454-60; PMID:12446453; http://dx.doi.org/10.1182/blood-2002-07-1984
24. Muindi JR, Modzelewski RA, Peng Y, Trump DL, Johnson CS. Pharmacokinetics of 1alpha,25-dihydroxyvitamin D3 in normal mice after systemic exposure to effective and safe antitumor doses. Oncology 2004; 66:62-6; PMID:15031600; http://dx.doi. org/10.1159/000076336
25. Hidalgo AA, Trump DL, Johnson CS. Glucocorticoid regulation of the vitamin D receptor. J Steroid Biochem Mol Biol 2010; 121:372-5; PMID:20398752; http://dx.doi.org/10.1016/j.jsbmb.2010.03.081
26. Yu WD, McElwain MC, Modzelewski RA, Russell DM, Smith DC, Trump DL, et al. Enhancement of 1,25-dihydroxyvitamin D3-mediated antitumor activity with dexamethasone. J Natl Cancer Inst 1998; 90:134-41; PMID:9450573; http://dx.doi. org/10.1093/jnci/90.2.134
27. Luo W, Karpf AR, Deeb KK, Muindi JR, Morrison CD, Johnson CS, et al. Epigenetic regulation of vitamin D 24-hydroxylase/CYP24A1 in human prostate cancer. Cancer Res 2010; 70:5953-62; PMID:20587525; http://dx.doi.org/10.1158/ 0008-5472.CAN-10-0617
28. Hershberger PA, Yu WD, Modzelewski RA, Rueger RM, Johnson CS, Trump DL. Calcitriol (1,25-dihydroxycholecalciferol) enhances paclitaxel antitumor activity in vitro and in vivo and accelerates paclitaxelinduced apoptosis. Clin Cancer Res 2001; 7:1043-51; PMID:11309356
29. Muindi JR, Yu WD, Ma Y, Engler KL, Kong RX, Trump DL, et al. CYP24A1 inhibition enhances the antitumor activity of calcitriol. Endocrinology 2010; 151:4301-12; PMID:20591973; http://dx.doi. org/10.1210/en.2009-1156